In a move to better secure the future of mRNA technology in Canada, Ottawa has signed on with COVID-19 shot maker, Moderna. The announcement of a domestic production plant comes as the pandemic highlighted a major gap in the country’s biotechnology sector. Global News Health reporter, Jamie Mauracher, has more.
- Mississauga, Ont., plant tapped to make mRNA for Moderna’s COVID-19 vaccines
- Moderna to take on COVID-19, flu with single booster vaccine
- Canada clinches more COVID-19 vaccines from Moderna in new agreement